Press Releases

RSS feed

Focus researcher : Matthew Wood at Myology 2016

Matthew Wood discusses the challenges of developing gene therapy

Myology 2016 – Day 2 : Muscle biology and neuromuscular junction

Throughout this second day, Myology 2016 was the stage of plenary sessions focused on “Fundamental muscle biology and neuromuscular junction.” This second day started with a lecture by Christophe Marcelle, initially in charge of the Australian Regenerative Medicine Institute at the University Monash in Melbourne, which has carried out the project Muscle formation, growth and … [Read more]

Myology 2016 – Day 1: 30 years after the discovery of the gene involved in Duchenne muscular dystrophy, myology has become the backbone of therapeutic innovation

Myology 2016, the 5th international congress of myology, organised by AFM-Téléthon, has started yesterday. Throughout this week, over 800 international experts on muscle and its diseases will gather at the Palais des Congrès in Lyon. This event will be the highlight of international myology in 2016, 30 years after the discovery of the gene involved … [Read more]

Progeria: discovery of therapeutic approach at I-stem

Thanks to a screening, Xavier Nissan’s team of the Institute for Stem cell Therapy and Exploration of Monogenic diseases (I-stem) has identified a compound able to treat progeria, a rare genetic disease inducing premature aging. A world premiere. The study was conducted with sick induced pluripotent stem cells (or iPSCs). The adult cells “rejuvenated” acting … [Read more]

5ème congrès International de Myologie, du 14 au 18 mars 2016

L’AFM-Téléthon organisera, du 14 au 18 mars 2016 à la Cité des Congrès de Lyon, son 5ème congrès international de myologie. Depuis sa première édition en 2000, le congrès international de myologie réunit les plus grands experts mondiaux de la discipline. Lors de sa dernière édition, en 2011, il a rassemblé 800 experts de 37 … [Read more]

Telethon fundraising event 2015 : 80 251 183 euros. More than ever THANK YOU!

At the end of a 30-hour TV marathon, the Telethon counter displays an extraordinary result of 80 251 183 euros. This outstanding outcome shows the support from millions of French citizens to the Telethon fight against rare diseases, including from London, New-York, Budapest…A strong visual symbol  remains the enlightened Towers of different cities all over … [Read more]

Telethon 2015 fundraising event: to speed up the biomedical research, more than ever

More than ever this year, as a result to its achievements, AFM-Telethon relies on the French citizen’s generosity to collect all the money requested to accelerate the research in gene and cell therapie. An area where this patient group is an historical precursor. Téléthon 2015 famous media event will be launched on the French Television … [Read more]

I-Motion’s mentor visite, the newest member of the AFM-Telethon galaxy

I-Motion is a new pediatric center for neuromuscular diseases which studies innovative biotherapies and is unique in Europe. The famous Canadian artist Garou, mentor of the Téléthon 2014 and mentor of I-Motion (Institute of Muscle-Oriented Translational Innovation.) came last Wednesday November 18th to launch it and meet with young patients, parents and healthcare professionals. Created … [Read more]

INGESTEM international congress and cell therapie

INGESTEM, I-Stem and biotherapies: 1st congress november 19-20th, 2015 INGESTEM, the national infrastructure in biology and health certified by the “Investissements d’Avenir” program (2012-2019), is the first French network of therapeutic innovations based on induced pluripotent stem cells (iPS) cells and human tissue engineering. Created by Professor Annelise Bennaceur-Griscelli, head of the Stem Cell Hub … [Read more]

Cell therapy in France & I-Stem: just 10 years from research to first clinical trials

I-Stem research laboratory was celebrating its 10 years in cell therapy R & D last October 27th in Paris: the right time to organize a press conference gathering international top medical opinion leaders in order to make an update on their pioneering work and the major steps forward to innovative stem cell therapies. Cross funded … [Read more]